drugset / Trial / NCT01148264
Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough Emesis
RandomizedParallel-groupDouble-blindSupportive care
Summary
This trial is designed to evaluate olanzapine compared to the metoclopramide in the treatment of break through emesis after prophylaxis with dexamethasone, 5-HT 3 receptor antagonists and aprepitant in patients receiving chemotherapy. Efficacy will be assessed using a modified MASCC questionaire with a visual analog scale.
Timeline
- Start
- 2010-07
- Primary completion
- 2013-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Metoclopramide | Small molecule | 10 mg | — |
| Subject | Olanzapine | Small molecule | 10 mg | — |
Indications
No indication recorded.